Rafael Bejar News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Aptose to Report First Quarter 2024 Financial Results and Provide Clinical Strategy Update on Tuesday, May 14, 2024

Aptose to Report First Quarter 2024 Financial Results and Provide Clinical Strategy Update on Tuesday, May 14, 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Rafael bejarSusan pietropaoloAptose biosciencesLifesci advisorsAptose biosciences incCorporate communications investor relationsReport first quarterProvide clinical strategy updateChief medical officerKey opinion leaderInvestor relationsSci advisors

Aptose Biosciences Inc (NASDAQ:APTO) Q4 2023 Earnings Call Transcript

Operator: Good afternoon. My name is Jonathan and I will be your conference operator today.

Soumit royAptose biosciencesSusan pietropaoloWilliam riceRafael bejarFletcher payneMd anderson cancer centerAptose biosciences incJones researchCall transcript marchAptose biosciences conference callFourth quarterYear ended decemberSenior vice presidentChief medical officerChief financial

Aptose Tuspetinib Clinical Data Featured in Oral Presentation at the 2023 ASH Annual Meeting

Aptose Tuspetinib Clinical Data Featured in Oral Presentation at the 2023 ASH Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAptose biosciencesRafael bejarExchange commissionInternational phaseUniversity of texas md anderson cancer centerAptosebiosciencesinc susan pietropaolocorporate communications investor relationsLeukemia research alliance programAptose biosciences incAmerican society of hematologyDepartment of leukemiaReporting complete response dataDemonstrate favorable safetyActive across broad populationsComplete response rate among all comersAchieve responses

Aptose Tuspetinib Clinical Data Featured in Oral

Aptose Tuspetinib Clinical Data Featured in Oral
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United statesRafael bejarSusan pietropaoloAptose biosciencesCorporate communications investor relationsInternational phaseAptose biosciences incUniversity of texas md anderson cancer centerAmerican society of hematologyDepartment of leukemiaExchange commissionLeukemia research alliance programReporting complete response dataDemonstrate favorable safetyActive across broad populationsComplete response rate among all comers

Aptose Presents Highlights from Clinical Update Webcast Featuring Latest Available Data on AML Drug Tuspetinib

Aptose Presents Highlights from Clinical Update Webcast Featuring Latest Available Data on AML Drug Tuspetinib
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesSusan pietropaoloRafael bejarAptose biosciencesAptose biosciences incLeukemia research alliance programUniversity of texas md anderson cancer centerEuropean school of haematologyDepartment of leukemiaInternational conferenceExchange commissionLifesci advisorsPresents highlightsClinical findingsHeavily pre treatedFavorable safety